coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Childwall & Wavertree PCN, Liverpool (LAD) · Health Inequalities Profile

    PCN U65582 · NHS Cheshire and Merseyside Integrated Care Board · 7 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    43,438

    Registered population

    62.5% aged 18–64

    19.9%

    Aged 65+

    ICB 19.0% · England 17.9%

    10.7%

    Ethnic minority (non-White)

    4.4% Asian · England 9.6%

    12.7%

    In IMD quintile 1

    ICB 31.9% · England 21.0%

    ~4,889

    Core20 residents (est.)

    Resident basis; registered basis ~5,997 · see page 3

    6,874

    Hypertension register

    +2.84% in 3 yrs · England +5.60%

    441

    SMI register

    5.3% of Liverpool (LAD)'s

    910

    COPD register

    Reviews +5.76% in 3 yrs

    Forecast to 2030

    7,595

    Hypertension patients, 2030

    +721 on today

    64.9%

    QRISK ≥20% on statins, 2030

    +3.09pp over 3 yrs

    5.3%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    43.2 pp
    Core20 share spans 43.2 pp across practices.

    Core20 share reaches 43.2% at Greenbank Drive Surgery and 27.8% at The Valley Medical Centre, where 60.7% report easy phone contact.

    58.1%
    Primary prevention lipid therapy trails England.

    Statin prescribing for QRISK ≥ 20% is 58.1% (England 63.6%) and for diabetes without CVD is 68.3% (England 73.2%), warranting a recall audit.

    80.2%
    Registered care and screening exceed national rates.

    COPD annual reviews reach 80.2% (England 76.4%), hypertension target control is 70.5% (England 70.3%), and cervical screening is 72.9% (England 66.8%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older population reaches 19.9% while recorded learning disability prevalence trails city benchmarks

    Childwall & Wavertree PCN registers 43,438 patients. Patients aged 65+ represent 19.9% (8,645 patients), above Liverpool (LAD) (15.6%), NHS Cheshire and Merseyside Integrated Care Board (19.0%), and England (17.9%). Children aged 0–17 comprise 17.6% (7,668 patients; Liverpool (LAD) 19.8%, ICB 19.2%, England 19.6%). Recorded learning disability prevalence is 0.4% (191 patients; England 0.6%; Liverpool (LAD) 0.6%). Catchment Census usual residents are 89.3% White (England 81.1%), 4.4% Asian (England 9.6%), 3.5% Mixed (England 3.0%), and 1.5% Black (England 4.2%).

    Age profile

    0–1717.6%
    18–6462.5%
    65+19.9%

    65+: ICB 19.0%, England 17.9%

    Ethnicity

    White89.3%
    Asian4.4%
    Mixed3.5%
    Black1.5%
    Other1.4%

    Older people · falls rows are Liverpool (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Liverpool LA)3,0352,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)87.4%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)58.6%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Liverpool LA)1,6521,0219552024/25
    Falls deaths, all ages, per 100,000 (Liverpool LA)27.518.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    PCN-wide Core20 share is 12.7%, but practice deprivation concentrates sharply up to 43.2%

    Core20 share (patients living in the most deprived 20% of areas in England, IMD deciles 1 and 2) is 12.7% PCN-wide, well below Liverpool (54.9%), NHS Cheshire and Merseyside ICB (31.9%), and England (21.0%). However, deprivation spans 43.2 pp across practices: Greenbank Drive Surgery has the highest concentration (43.2%; 2,540 estimated patients), ahead of The Valley Medical Centre (27.8%; 2,300). Practice estimates sum to 5,997 patients (13.8% weighted share), conflicting with 4,889 estimated residents. This suggests outreach could prioritise targeting across these two practices.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Greenbank Drive43.2% · 2,540 patients
    Valley27.8% · 2,300 patients
    Lance Lane11.7% · 751 patients
    Greenbank Road6.8% · 406 patients
    Penny Lane0.0% · 0 patients
    Beacon Health0.0% · 0 patients
    Rutherford0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    441

    SMI register

    1.00% recorded prevalence

    191

    Learning disability register

    0.43% recorded prevalence

    14

    Care homes, 612 beds

    In the PCN catchment

    10.3%

    Provide unpaid care

    Liverpool (LAD), Census 2021

    The PCN records 441 patients on the severe mental illness register (1.0%; England 1.0%; Liverpool (LAD) 1.4%). Catchment areas contain 14 care homes with 612 beds. Wider city context includes 35 people sleeping rough in the autumn 2025 snapshot and an unpaid care ceiling estimate of 4,474 people (10.3% borough rate); these are local authority measures, not PCN patient counts.

    Severe mental illness: physical health checks

    Recorded blood pressure checks reached 81.7% of the SMI register (England 83.4%) and BMI recording reached 80.0% (England 82.1%). Both physical health check components trail national levels.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    6,874

    Hypertension register

    +2.84%

    Register growth, 3 yrs

    Liverpool (LAD) +2.01% · England +5.60%

    +1.65pp

    BP control, under 80

    ≤140/90 · +2.32pp aged 80+

    +721

    More patients by 2030

    Forecast 7,595 (16.47%)

    Hypertension case-finding and control

    Hypertension register prevalence is 15.6% (6,874 patients), above Liverpool (14.0%) and England (15.2%) but below the ICB (16.8%). Three-year register growth of +2.8% trails England (+5.6%) and the ICB (+5.5%). Among registered patients, 89.0% have a recent blood pressure reading (England 90.0%), and overall treatment to target reaches 70.5%, exceeding England (70.3%) and Liverpool (69.8%). However, blood pressure control for patients aged under 80 is 66.7%, trailing England (67.8%). With register growth trailing England despite above-average target control, clinical audit could investigate potential case-finding variation.

    Lipids and statins

    Statin coverage for QRISK ≥ 20% is 58.1% (Liverpool 65.6%; England 63.6%), and diabetes primary prevention is 68.3% (Liverpool 71.6%; England 73.2%). Adult lipid prescribing is 1,936 items per 1,000 (England 4,100). Primary prevention statin coverage trails national benchmarks, highlighting an opportunity to expand cardiovascular risk recall.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202669,255£1.70£1.71£1.86£117,734
    Cardiovascular (all), 202596,116£4.56£4.37£3.33£438,289

    In 2026, the PCN prescribed 69,255 lipid-regulating items at £1.70 per item, below Liverpool (£1.82), the ICB (£1.71) and England (£1.86). Across these items, the PCN spent £11,081 less than at England's unit cost. Prescribing at a lower unit cost than England benchmarks leaves treatment expansion for eligible high-risk patients as the main opportunity.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +9.79%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.22%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.6% (2,749 patients), matching England (6.6%), with 66.8% reviewed within 12 months (England 65.7%), leaving about 910 unreviewed. Second-hand smoke recording for ages 6–19 is 75.5%, below England (78.8%). Prescribing of asthma management items for ages 5–19 is 1,614 per 1,000 (England 1,488; Liverpool 2,457). Meanwhile, the COPD register contracted by -5.9% over three years (England +2.6%) to 910 patients (2.1% vs Liverpool 3.0%), with review coverage reaching 80.2% (England 76.4%).

    Cancer register and children's immunisation

    Cancer prevalence reached 4.4% (1,949 patients; England 3.8%), growing +10.1% over three years (England +9.0%). In childhood immunisation, age-5 MMR dose 1 achieved 91.5% (England 91.7%), but dose 2 reached 85.1% (England 82.8%), a 6.4 pp difference and below the 95.0% target by 9.9 pp, reaching a 20 pp dose difference at The Valley Medical Centre.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months91.9%

    England 91.0%

    6-in-1 complete primary course at 24 months91.4%

    England 92.2%

    MMR dose 1 at 24 months91.4%

    England 88.3%

    MMR dose 2 at age 585.1%

    England 82.8%

    4-in-1 pre-school booster at age 584.0%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.5%

    Cheshire and Merseyside ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,640

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Cheshire and Merseyside ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%11%2,354
    Breast87.1%85.4%11%2,083
    Prostate52.3%53.2%12%2,037
    Bowel44.9%47.0%16%1,674
    Skin cancer86.9%87.8%21%932

    Wider-system staging is reported at ICB level. In 2022, 55.5% of cancers with a known stage (7,482 of 13,490) across NHS Cheshire and Merseyside ICB were diagnosed at stage 1 or 2, near England (55.3%) but 19.5 pp below the 75.0% national ambition. Known-stage coverage was 72.8% (13,490 of 18,522; England 67.0%). Closing this gap would require 2,635.5 extra early-stage cases across the ICB. In primary care, PCN cervical screening reaches 72.9% (England 66.8%), but Beacon Health Mossley Hill records 65.7%. Targeted screening recall could help practices trailing national benchmarks support earlier diagnosis.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    Cancer waiting times reflect wider acute performance rather than PCN delivery. In Jul 2026 (provisional), Liverpool Women's NHS Foundation Trust achieved 69.1% on the 62-day referral to treatment standard, falling 15.9 pp below the 85.0% standard and trailing England (71.2%), Liverpool University Hospitals NHS Foundation Trust (73.3%), NHS Cheshire and Merseyside Integrated Care Board (76.2%), and Mersey and West Lancashire Teaching Hospitals NHS Trust (78.0%). On the 28-day faster diagnosis standard, the trust met the 75.0% standard at 75.7% (ICB 77.2%, England 79.3%). Slower treatment initiation at provider level may lengthen waits for referred patients.

    Pathways within standard (%)Liverpool Women'sLiverpoolMersey and West LancashireCheshire and Merseyside ICBEngland
    28-day faster diagnosis (75%)75.7375.4772.3977.2579.32
    31-day treatment (96%)85.4290.5195.4695.7192.50
    62-day referral to treatment (85%)69.0973.2677.9676.2371.16
    Community services activityLiverpool residentsCheshire and Merseyside ICB
    Care contacts127,380541,280
    Referrals15,67597,150
    Patients with a contact24,970146,240

    Community services (residents of Liverpool), Jun 2026 (provisional). In Jun 2026 (provisional), adults aged 65 and over accounted for 65.4% of community service contacts among Liverpool residents (83,300 of 127,380 recorded contacts). These data reflect borough-level community activity rather than PCN-level delivery. Primary care coordination with community teams is critical given high older-adult activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice telephone access spans 25.9 pp across practices despite strong overall experience ratings

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Valley10927.860.7%73.2%91.0%
    Penny Lane Surgery1240.080.6%69.4%90.2%
    Greenbank Road1016.872.9%44.7%86.6%
    Beacon Health1040.080.8%78.3%85.6%
    Lance Lane11211.763.4%72.5%83.5%
    Greenbank Drive10243.281.6%75.4%80.9%
    Rutherford1050.086.5%78.4%80.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNLiverpool (LAD)AssetPCNLiverpool (LAD)
    Care homes (catchment)14 (612 beds)n/aSchools (catchment)74n/a
    Children's centres426Places of worship50240
    Libraries417Homelessness support (VCS)n/a1
    Primary schools (LA maintained)1691Primary academies420
    Special schools28

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Primary prevention statin recall

    Lipid therapy for QRISK ≥ 20% is 58.1%, below England (63.6%) by 5.4 pp; statin treatment in diabetes aged 40+ without CVD is 68.3%, below England (73.2%) by 4.9 pp. Moderate effort to run.

    Evidence base: delivery measure for eight care processes and three treatment targets; shortfall here is what shows up later as emergency admission.

    Policy anchor: NHS Diabetes Prevention Programme and the eight care processes / three treatment targets.

    Option 2

    COPD case-finding and coding audit

    The COPD register (910 patients; 2.1%) contracted by -5.9% over 2023 to 2025 (England +2.6%) and trails Liverpool (3.0%), with an unadjusted benchmark range of -87 to +376 patients. Moderate effort to run.

    Evidence base: the copd register is the cohort for spirometry-confirmed diagnosis, annual review and inhaler technique; register size and growth set the workload those interventions must cover.

    Policy anchor: Core20PLUS5 adults: chronic respiratory disease (COPD vaccination and exacerbation reduction); Tobacco and Vapes Bill: smokefree generation.

    Option 3

    Learning disability register validation

    Recorded learning disability prevalence is 0.4% (191 patients) after falling 6.8% over 2023 to 2025 (England +5.4%), with an unadjusted benchmark gap of +62 to +64 patients against Liverpool and England (0.6%). Low cost, quick to run.

    Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.

    Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Learning disability register audit (p2)Learning disability: QOF prevalence75% annual health checks (Network Contract DES) · Oliver McGowanPCN
    Targeted Core20 practice outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    SMI physical check outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension case finding audit (p5)Hypertension: QOF prevalenceCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school MMR booster recall (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted cervical screening recall (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026Practice
    Telephone access and triage review (p9)GPPS good overall experience of the practice10YHP, hospital to communityPractice
    Option 1 · Primary prevention statin recall (p12)Patients with QRISK ≥ 20% treated with lipid lowering therapy · Patients with diabetes (40+ yrs no history of CVD) treated with a statin (denominator incl. PCAs) · Core20 cohort (IMD quintile 1)NHS Long Term Plan (diabetes) and National Diabetes AuditPCN & Practice
    Option 2 · COPD case-finding and coding audit (p12)COPD register · COPD: QOF prevalence · Core20 cohort (IMD quintile 1)Core20PLUS5 approach · Tobacco and Vapes BillPCN & Practice
    Option 3 · Learning disability register validation (p12)Learning disability register · Learning disability: QOF prevalence · Core20 cohort (IMD quintile 1)75% annual health checks (Network Contract DES) · Oliver McGowanPCN & Practice
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15